Simon Baker
Stock Analyst at Redburn Atlantic
(0.86)
# 3,704
Out of 4,761 analysts
8
Total ratings
25%
Success rate
-6.5%
Average return
Main Sectors:
Stocks Rated by Simon Baker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Upgrades: Buy | $13 | $1.95 | +566.67% | 1 | Nov 15, 2024 | |
| BNTX BioNTech SE | Upgrades: Buy | $165 → $170 | $120.01 | +41.65% | 3 | May 17, 2023 | |
| QGEN Qiagen | Initiates: Buy | n/a | $39.57 | - | 1 | Oct 14, 2021 | |
| ABT Abbott Laboratories | Initiates: Neutral | n/a | $134.92 | - | 1 | Oct 14, 2021 | |
| HOLX Hologic | Initiates: Neutral | n/a | $64.49 | - | 1 | Oct 14, 2021 | |
| FOXA Fox Corporation | Upgrades: Hold | $29 → $24 | $56.95 | -57.86% | 1 | Apr 8, 2020 |
Autolus Therapeutics
Nov 15, 2024
Upgrades: Buy
Price Target: $13
Current: $1.95
Upside: +566.67%
BioNTech SE
May 17, 2023
Upgrades: Buy
Price Target: $165 → $170
Current: $120.01
Upside: +41.65%
Qiagen
Oct 14, 2021
Initiates: Buy
Price Target: n/a
Current: $39.57
Upside: -
Abbott Laboratories
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $134.92
Upside: -
Hologic
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $64.49
Upside: -
Fox Corporation
Apr 8, 2020
Upgrades: Hold
Price Target: $29 → $24
Current: $56.95
Upside: -57.86%